Skip to content
TirzepatideReport

Tirzepatide monograph · Evidence review

Livv Tirzepatide Review: Cost & Honest Verdict (2026)

An honest 2026 review of Livv tirzepatide — a confirmed starting price, both semaglutide and tirzepatide, and thin public program disclosure.

Researched & written by Alan Pierce · last updated

Clinical Pharmacology Writer

On this page

Editorial pick

CoreAge Rx

$149/mo flat

Doctor-reviewed tirzepatide with one flat price and built-in human support.

Advertising disclosure · we may earn a commission at no extra cost to you.

Check availability
vs median
$120/mo below the $269 median
Market
$109–$429/mo across 396 providers
Dispensed
Compounded tirzepatide (503A)

Popular alternative

HumeCare+

HumeCare+ is the GLP-1 arm of Hume Health, the body-composition scale company: compounded tirzepatide blended with vitamin B12 and glycine, sold alongside a body analyzer that reads fat and muscle weekly.

$199/mo (microdose)

Check HumeCare+ availability

Livv: $249/month appears on the site, consistent with roster data placing that as the tirzepatide starting price. Every fact here comes from the company's own published program.

What Livv is

Livv is a telehealth weight-loss provider, offering compounded tirzepatide programs. An online intake is reviewed by a licensed clinician, with pricing published before you start.

§ Livv — Confirmed Pricing, Limited Disclosure

ItemStatus
Tirzepatide$249/mo starting dose
Named pharmacyNot found
AccreditationNot found
Verified: $249/mo starting dose. Not found: named pharmacy, accreditation badge.

What Livv costs

$249/month at the starting dose. This is a starting-dose figure — confirm what a titrated dose costs before assuming it stays flat.

Limited public disclosure

Worth flagging directly: limited public information exists about Livv's program details beyond pricing and molecule availability — no named compounding pharmacy, no accreditation badge, and no named clinical leadership were found.

The brand-vs-compounded question

Livv dispenses compounded tirzepatide, not the FDA-approved branded product. Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture.

How the care model holds up

Livv's real strength: both semaglutide and tirzepatide available through a straightforward compounded telehealth intake. The trade-offs: this review found very limited public information about the program beyond pricing, no named compounding pharmacy, and no visible accreditation. As with any GLP-1 program, and especially one this thin on public disclosure, ask directly about the compounding pharmacy and your state's coverage before committing; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-11, and better than semaglutide head-to-head2 — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

Livv's confirmed starting price is a reasonable baseline, but this review found very little else to verify — no named pharmacy and no accreditation badge. Ask directly before committing. For providers with fuller public disclosure, compare it against BiltRx or Fresh Day Meds. For a similarly thin-disclosure provider with a genuine money-back guarantee, see Nalena. See our best tirzepatide providers ranking for the full field.

Frequently asked questions

How much does tirzepatide cost through Livv?

$249/month at the starting dose.

Does Livv name its compounding pharmacy?

No — this review found no named compounding pharmacy or accreditation badge.

Does Livv offer semaglutide too?

Yes.

References(2)

  1. Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A, and the SURMOUNT-1 Investigators (2022). Tirzepatide Once Weekly for the Treatment of Obesity.. New England Journal of Medicine. PMID: 35658024. https://pubmed.ncbi.nlm.nih.gov/35658024/
  2. Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon BL, Bays HE, et al. (2025). Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5).. New England Journal of Medicine. PMID: 40353578. https://pubmed.ncbi.nlm.nih.gov/40353578/

About the author

Alan Pierce

Clinical Pharmacology Writer

About Tirzepatide Report · How we verify prices · This page last updated August 2026

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.